Patent · US Active

Organic compounds

US8703761B2 · kind B2 · utility

7Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 14, 2009
Grant dateApr 22, 2014
Priority date
Expiry dateSep 23, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D405/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I):where A is an optionally substituted heteroaryl, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.